Compounding pharmacist Brad White was recently featured on the Made to Be Whole podcast, diving deep into the power of Low Dose Naltrexone (LDN) and the essential role of compounding pharmacies in personalized healthcare.
Read More
Epilepsy is a broad term used to describe people who suffer multiple seizures in their life time. Seizures are defined as sudden, uncontrolled electrical brain activity. Depending on how the brain looks at these electrical currents a person may change behavior, display abnormal movement or even lose consciousness. Low Dose Naltrexone has shown promise as an alternative treatment option for seizure disorders.
Read More
Naltrexone is classified as an opioid antagonist. Naltrexone blocks opiate drugs from binding to the opioid receptors, which can result in increased endorphin and enkephalin release. This causes a biological response that results in reduced signaling and release of inflammatory substances, nerve cell inflammation and autoimmune mediators. LDN has been studied across a wide variety of autoimmune conditions and cancer diagnosis.
Read More
The LDN Research Trust released a documentary earlier this month that provides education for patients that are suffering from chronic pain and are dependent on opioid prescription medication.
Read More